top of page
CONFERENCE
SPEAKERS
Sir Ashley Bloomfield, KNZMSir Ashley Bloomfield has 25 years’ experience in public policy and health leadership, including at the WHO in Geneva. His professional areas of interest are non-communicable disease prevention and control, and addressing health inequities. He was New Zealand’s Director-General of Health from June 2018 to July 2022 and led the country’s health response to the COVID-19 pandemic. He was appointed a Knights Companion of the New Zealand Order of Merit for services to public health. | Lady Tureiti Moxon (Ngāti Pāhauwera, Ngāti Kahungunu, Kai Tahu)Lady Tureiti Moxon, Chair of the National Urban Māori Authority, is also Managing Director of Te Kōhao Health, a service provider in Kirikiriroa/Hamilton. With an extensive governance background, she sits on several advisory panels, including the Ministry of Health Māori Monitoring Group. She contributed to Ngāti Pāhauwera's treaty claim resolution and is an advocate in Waitangi Tribunal hearings. | Te Puea Winiata, ONZM (Ngāti Ranginui, Ngāti Te Rangi, Ngāti Tamarāwhao, Tūhoe, Tainui)Te Puea has dedicated her career to the health and social sector. For 13 years, she's been the CEO of Turuki Health Care in South Auckland, with a particular passion for Primary Health Care. A key service they offer is the School based Health Team and GP in Schools programme, emphasizing respiratory care for tamariki, rangatahi, and their whanau in the region. | Dr Rawiri McKree Jansen (Ngāti Raukawa, Ngāti Hinerangi)Formerly a Māori language teacher, Dr Rawiri McKree Jansen completed his medical undergraduate studies in 2000. For many years he provided clinical teaching, Te Reo and Tikanga Māori programmes for Māori health professionals across New Zealand. He has been the Chairperson of Te Ataarangi Trust and Te Ohu Rata o Aotearoa. He is now providing clinical leadership towards Maori health equity as a General Practitioner and interim Chief Medical Officer for Te Aka Whai Ora. |
---|---|---|---|
Professor Richard BeasleyProf. Richard Beasley is the Director of the Medical Research Institute of New Zealand. He is Professor of Medicine at Victoria University of Wellington, an Adjunct Professor at the University of Otago and a Visiting Professor, at the University of Southampton, UK. He is on the ARFNZ Scientific Advisory Board and was the lead author of the NZ Adolescent and Adult Asthma Guidelines 2020. His research interests in respiratory medicine are primarily in the field of clinical management. | Dr James FingletonDr James Fingleton is a respiratory physician at Wellington Hospital, with a sub-specialist interest in asthma and COPD. He is current President of the Thoracic Society of Australia New Zealand (TSANZ) NZ branch and Chief Investigator of the TSANZ NZ National Asthma Audit. James also serves as Medical Director of the Asthma and Respiratory Foundation New Zealand and teaches as a Senior Clinical Lecturer at the University of Otago, Wellington. | Dr Amy ChanDr Amy Chan is clinical academic pharmacist working between the University of Auckland, and in primary care. For nearly 15 years, Amy has been conducting research into the intersection between digital technologies and asthma management. Amy is a member of the European Respiratory Society Clinical Research Collaboration CONNECT which aims to move digital innovations towards connected respiratory care, the Respiratory Effectiveness Group, Open Digital Health and the PSA Respiratory Taskforce. | Dr Stuart JonesDr Stuart Jones is the Clinical Head of Respiratory Medicine at Counties Manukau Health and a member of ARFNZ’s Scientific Advisory Board. As a past Medical Director of ARFNZ, he led the development of New Zealand’s first, evidence-based guidelines for assessing and treating COPD, alongside Professor Bob Hancox and other experts. Stuart is the immediate past President of the NZ branch of the Thoracic Society of Australia and New Zealand and is a current board member. |
Sarah ButlerSarah has worked across all aspects of paediatric respiratory care from intensive care to outpatients. She was instrumental in setting up a Physiotherapy Bronchiectasis Outreach service and a combined Breathing Pattern Dysfunction Clinic with the Starship Psychiatric Liaison team. She is a Clinical Centre Leader looking after physiotherapy students within Waitemata District of Te Whatu Ora and works clinically with adult respiratory patients. She is a regular postgraduate lecturer at AUT. | Betty PootBetty is a Nurse Practitioner at Te Whatu Ora Capital Coast and Hutt Valley and is a Senior Lecturer at Victoria University of Wellington. As a clinician, Betty works across primary and secondary care settings and has a special interest in the management of patients with bronchiectasis. | Hayden McRobbie, MB ChB (Otago), PhD (London), FASLM, FNZCPHMProfessor McRobbie is the Regional Director, Northern Region, of the National Public Health Service, Te Whatu Ora – Health New Zealand. He holds a medical degree from the University of Otago (1996) and a doctorate from the University of London (2008). With over 20 years of experience in preventive medicine, he is a Fellow of the New Zealand College of Public Health Medicine and a Professor in Public Health Interventions at the University of New South Wales. | Associate Professor Nevil PierseNevil Pierse is co-leader of He Kainga Oranga/Housing and Health Research Programme. His work focuses on the design and implementation of experiments to improve the home and community environments. He is currently working on the Healthy Housing Initiative which looks at home interventions to prevent rehospitalisation of children with housing related disease. Nevil has a keen interest in big data and leads five Housing and Health projects on the integrated data infrastructure. |
Dr Dale Bramley (Ngā Puhi) | Dr Adrian Trenholme | Nicola CornaNicola is a nurse practitioner who has worked in the respiratory team at Counties Manukau DHB for 20 years. She has been involved in running outpatient services for a variety of respiratory conditions including severe asthma, sleep disorders and post covid. Nicola serves on several working groups including local DHB asthma and COPD pathways and initiatives. Nicola was involved in developing New Zealand’s first national COPD guidelines, and is on the ARFNZ’s Scientific Advisory Board. | Professor Janet HoekJanet is a Professor in the Department of Public Health at the University of Otago, Wellington. She is particularly interested in how policy measures can more effectively manage the appeal, availability and design of tobacco and nicotine products. She has undertaken several studies to explore how people who smoke interpret and respond to smokefree interventions; she has estimated the effects different smokefree interventions may have, including uptake of ENDS, and critically reviewed arguments. |
Sarah CandySarah Candy is an experienced physiotherapist who has worked extensively in adult respiratory care. She is currently employed as the Better Breathing Coordinator at Te Whatu Ora Counties Manukau. She is also a PhD candidate with AUT and her research has focused on developing an mHealth intervention to increase the reach of Pulmonary Rehabilitation in New Zealand. | Dr Michelle BalmDr Michelle Balm is an Infectious Diseases Physician and Clinical Microbiologist. She completed her training in New Zealand and Singapore. She’s been the Clinical Lead for Infection Services since 2016, and was the Clinical Lead for the COVID-19 response at Capital, Coast and Hutt Valley DHB. She has been on the MoH Infection Prevention and Control Technical Advisory group since September 2021 and Chair of IPC TAG since July 2022. | Sharon PihemaAs the Māori Community Liaison Officer, Sharon actively supports the Foundation's Māori Engagement Strategy, forming strong connections with whanau, hapū, and iwi to address respiratory health needs. With experience in population health, service development, and whanau engagement, she held significant roles at Tairāwhiti DHB, The National Heart Foundation, and The Health Quality and Safety Commission. | Susan WoodardSusan Woodard is one of the few New Zealanders living with non-tuberculous mycobacterium lung infection (NTM). Susan has undertaken research to learn more about her condition and is involved with the NTM Patient Care UK group, where she is on the steering group writing standards of care for the NHS. She is also hoping to start a New Zealand support group for others with NTM. |
Tony TiaTony Tia is a 48-year-old New Zealand born Samoan. Tony has lived with COPD most of his life and says that bronchiectasis is like ‘his middle name’. Tony uses the sporting analogy of living with bronchiectasis as being like a ‘journeyman’; “you could say that I am that journeyman in respect to living with bronchiectasis.” Tony will share his story of what it means to live day-to-day and how he lives life to the fullest with bronchiectasis as his companion. |
bottom of page